4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001193125-26-047535
Director acquired 8,713,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC Director | 2026-02-09 | Option exercise | +5,809,000 | 5,809,000 | I | ||
| Fairmount Funds Management LLC Director | 2026-02-09 | Option exercise | +2,904,000 | 2,904,000 | I | ||
| Derivatives | |||||||
| Fairmount Funds Management LLC Director | 2026-02-09 | Option exercise · Series C Preferred Stock | −5,809 | 1,148 | I | ||
| Fairmount Funds Management LLC Director | 2026-02-09 | Option exercise · Series C Preferred Stock | −2,904 | 574 | I | ||
Loading xslF345X05/ownership.xml…